Canopy Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$470K Sell
937
-64
-6% -$30.7K 0.14% 132
2026
Q1
$492K Sell
1,001
-20
-2% -$10.9K 0.17% 112
2025
Q4
$592K Buy
1,021
+40
+4% +$22.6K 0.19% 102
2025
Q3
$476K Sell
981
-134
-12% -$62.4K 0.16% 110
2025
Q2
$452K Sell
1,115
-1,068
-49% -$447K 0.17% 114
2025
Q1
$1.09M Sell
2,183
-67
-3% -$36.3K 0.42% 53
2024
Q4
$1.17M Buy
2,250
+999
+80% +$549K 0.45% 46
2024
Q3
$774K Sell
1,251
-17
-1% -$10.1K 0.33% 71
2024
Q2
$701K Sell
1,268
-2
-0.2% -$1.15K 0.33% 72
2024
Q1
$738K Buy
1,270
+171
+16% +$96K 0.36% 67
2023
Q4
$584K Buy
+1,099
New +$532K 0.36% 67

Other funds holding TMO

Canopy Partners's TMO Position: Q2 2026 in Review

Canopy Partners reduced its Thermo Fisher Scientific (TMO) stake by 6.4% in Q2 2026, selling an estimated $30.7K and leaving 937 shares worth $470K. The position accounts for 0.14% of the portfolio, ranked #132.

Canopy Partners first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.17M in Q4 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Canopy Partners held 937 shares of Thermo Fisher Scientific worth $470K as of Q2 2026.
  • Canopy Partners sold 64 Thermo Fisher Scientific shares in Q2 2026, an estimated $30.7K.
  • Thermo Fisher Scientific made up 0.14% of Canopy Partners's portfolio in Q2 2026, its #132 holding.
  • Canopy Partners first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Canopy Partners's Thermo Fisher Scientific position peaked at $1.17M in Q4 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Canopy Partners's 13F filing for Q2 2026, filed 22 Jul 2026.